Should Day Traders Avoid Joy Global Inc. (JOY), SolarCity Corp (SCTY), and Ocata Therapeutics Inc (OCAT)?

Posted by admin December 18, 2014 0 Comment 1162 views

New York, NY – GDP INSIDER  –  12/18/2014.

This investment analysis discusses Joy Global Inc.(NYSE:JOY), SolarCity Corp(NASDAQ:SCTY), and Ocata Therapeutics Inc(OTCMKTS:OCAT)

Joy Global Inc.(NYSE:JOY) reported its fourth quarter fiscal 2014 operating results yesterday. The figures included a bookings of $783 million, which represents a 27% decrease from the figure recorded during the same period of the previous fiscal year. The stock traded for a new 52 week low of $44.45 yesterday before finishing the day at a closing price of $46.14 after a 0.2% boost of nine cents. Despite yesterday’s menial increase in value, Joy Global Inc. appears to be on the decline. The company has a beta of 1.48, meaning that its stock is 48% more volatile than the market.

Is Joy Global Set To Collapse? Learn More About JOY’s Direction With Our Free Analysis.

SolarCity Corp(NASDAQ:SCTY) announced on Dec. 11th that it had joined with Bank of America Merrill Lynch to announce an estimated $400 million in solar power projects for 2014 and 2015. The projects will enable Americans to install solar panels on their houses. The company’s beta of 5.664 indicates that the stock is 466.4% more volatile than the market. SolarCity Corp. has an earnings per share (TTM) of $-0.28, which could scare off investors. The company has a market capitalization of $4.84 billion.

Will SolarCity Hit Rock Bottom? Receive A Free SCTY Analysis And Get A Jump On Wall Street.

Ocata Therapeutics Inc(OTCMKTS:OCAT) announced an intention to offer and sell 10,000,000 shares of its common stock on Dec. 2nd, 2014. As part of the offering, Ocata retained a 30-day option to purchase 1,500,000 shares of its common stock. The company has an earnings per share (TTM) of $-1.37, a figure that could cause some investors to avoid the stock. However, Ocata Therapeutics Inc. did finish yesterday’s trading at a closing price of $6.75 after an 8% boost of fifty cents. This mark is just $1.75 higher than its 52 week low and is $9.25 lower than its one-year target estimate.

Can Ocata Therapeutics Maintain Its Upward Momentum? Click Here For A Free OCAT Analysis And Make A Smart Investment Decision.

About HotStockGains provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word BREAKOUT to 555888 from your cell phone.

Additionally, HotStockGains free newsletter provides market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks.

Disclosure:  HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit for complete risks and disclosures.

Write Your Comment